News for Abbott Laboratories - Google Finance

Abbott Laboratories lifted to buy at Goldman Sachs

Mon, 20 May 2013 08:04:13 GMT

Abbott Laboratories lifted to buy at Goldman Sachs
MarketWatch - May 20, 2013

Abbott Laboratories lifted to buy at Goldman Sachs. 0 Comments. Tweet. new. Portfolio Relevance. LEARN MORE. Want to see how this story relates to your portfolio?

UPDATE: Goldman Sachs Upgrades Abbott Laboratories; Growth Is Poised To ...

Mon, 20 May 2013 14:48:21 GMT

UPDATE: Goldman Sachs Upgrades Abbott Laboratories; Growth Is Poised To ...
Benzinga - May 20, 2013

In a report published Sunday, Goldman Sachs analyst David H. Roman upgraded the rating on Abbott Laboratories (NYSE: ABT) from Neutral to Buy and raised the price target on the company from $38.00 to $44.00.

Goldman Sachs Upgrades Abbott Labs to “Buy;” 20% Upside (ABT) - Dividend.com (blog)
Abbott gets some analyst love for diversifying, meeting generic threats - MarketWatch (blog)

Abbott Laboratories Stock Checkup for May

Fri, 17 May 2013 22:30:45 GMT

Abbott Laboratories Stock Checkup for May
Motley Fool - May 17, 2013

How does Abbott Laboratories stock fare against its peers in health care? Let's use the SPDR Health Care Select ETF (NYSEMKT: XLV ) as a proxy to represent the health-care industry as a whole.

July Options Now Available For Abbott Laboratories (ABT)

Mon, 20 May 2013 17:25:45 GMT

July Options Now Available For Abbott Laboratories (ABT)
Forbes - May 20, 2013

Investors in Abbott Laboratories Abbott Laboratories (NYSE: ABT) saw new options begin trading today, for the July expiration.

Abbott Laboratories' Management Presents at UBS Global Healthcare ...

Wed, 22 May 2013 14:02:14 GMT

Abbott Laboratories' Management Presents at UBS Global Healthcare ...
Seeking Alpha - 5 hours ago

Hi, good morning, everyone. Thanks for participating in the UBS Healthcare Conference this year. Today, we are very pleased to have Abbott Labs present. Kicking it off will be Tom Freyman, long time CFO of Abbott and after that we are very glad to have ...

ABBOTT LABORATORIES : Abbott to Present at Deutsche Bank 38th Annual ...

Wed, 22 May 2013 12:36:54 GMT

ABBOTT LABORATORIES : Abbott to Present at Deutsche Bank 38th Annual ...
4-traders (press release) - 6 hours ago

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare.

Jury orders Abbott Labs to pay $2 million in Humira suit

Sat, 11 May 2013 03:00:26 GMT

Jury orders Abbott Labs to pay $2 million in Humira suit
Chicago Business Journal - May 11, 2013

In the first Humira lawsuit to go to trial, a Cook County jury has ordered Abbott Laboratories to pay $2.24 million to the plaintiff.

Perdue Kidd & Vickery Wins First Humira Trial - Abbott Laboratories To Pay ... - PR Newswire (press release)
Abbott, AbbVie Hit With $2.2M Verdict In Humira Suit - Law360 (subscription)

Abbott Laboratories Stock Is Half What It Used to Be

Tue, 30 Apr 2013 18:30:31 GMT

Abbott Laboratories Stock Is Half What It Used to Be
Motley Fool - Apr 30, 2013

Abbott Laboratories stock hit a high in October of last year of 72.47, but when the new year hit, the company split in two, spinning its drug assets into AbbVie (NYSE: ABBV ) .

Abbott, AbbVie seek investors' love - Crain's Chicago Business
Humira Was A Factor In Widespread Infection, Doctor Testifies - Law360 (subscription)

Pressure Mounts to Remove GMOs from Infant Formula; Abbott Laboratories ...

Fri, 03 May 2013 14:46:20 GMT

Pressure Mounts to Remove GMOs from Infant Formula; Abbott Laboratories ...
Truth-Out - May 3, 2013

Cornucopia, WI -- Shareholders of Abbott Laboratories will vote on whether the manufacturer of Similac, a leading brand of infant formula, should adopt a policy of sourcing ingredients that have not been genetically engineered.

Yawn Your Way to Retirement With Abbott Laboratories Stock

Tue, 23 Apr 2013 02:56:12 GMT

Yawn Your Way to Retirement With Abbott Laboratories Stock
Motley Fool - Apr 23, 2013

After spinning off its pharmaceutical business -- and most of its dividend, essentially -- you may think Abbott Laboratories (NYSE: ABT ) is relegated to a boring medical-device company. Heart stents just aren't as sexy as the megablockbuster drugs now ...

Abbott Laboratories PT Raised to $38.00 (ABT) - Daily Political
Abbott Laboratories Stock Rating Reaffirmed by Barclays Capital (ABT) - Mideast Time